Skip to content

PROCHIPHAR: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PROCHIPHAR

BE 0436.168.418
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€8,838
2024 · -€27,694+€36,532
Equity
€955,867
2024 · €947,029+€8,838
Cash
€10,301
2024 · €18,266-€7,965
Balance sheet total
€1.2m
2024 · €1.2m+€14,725

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€679,742

    up €679,742 (+441.7%), from €153,876 to €833,618

    of which Other amounts receivable: +€636,025

  • Current investments -€640,000

    down €640,000 (-71.9%), from €890,000 to €250,000

  • Tangible fixed assets -€16,965

    down €16,965 (-18.9%), from €89,955 to €72,990

    of which Furniture and vehicles: -€13,619

Equity and liabilities
  • Trade debts -€17,454

    down €17,454 (-63.2%), from €27,630 to €10,176

  • Accrued charges and deferred income +€12,029

    up €12,029 (+90.3%), from €13,321 to €25,350

Income statement
  • Gross operating margin +€48,482

    up €48,482, from -€22,552 to €25,930

  • Financial income -€11,861

    down €11,861 (-40.8%), from €29,043 to €17,182

  • Taxes +€1,058

    up €1,058 (+2044.7%), from €52 to €1,110

  • Financial charges -€885

    down €885 (-6.4%), from €13,784 to €12,899

  • Other operating charges -€495

    down €495 (-20.0%), from €2,472 to €1,978

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€27,694
Gross operating margin +€48,482
Staff costs -€8
Depreciation -€402
Other operating charges +€495
Financial income -€11,861
Financial charges +€885
Taxes -€1,058
Result 2025 €8,838

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€646,644
Investment +€638,679
Financing €0
Cash 2024 €18,266
Net result for the year +€8,838
Depreciation +€18,286
Smaller working-capital items +€87
Receivables within one year -€679,742
Trade debts -€17,454
Tax, wage and social debts +€8,912
Other debts +€2,399
Accrued charges and deferred income +€12,029
Investment in fixed assets (net) -€1,321
Current investments +€640,000
Cash 2025 €10,301
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,160,601 €1,175,326 +€14,725 +1.3%
Fixed assets 21/28 €89,955 €72,990 -€16,965 -18.9%
Tangible fixed assets 22/27 €89,955 €72,990 -€16,965 -18.9%
Plant, machinery and equipment 23 €829 €507 -€323 -38.9%
Furniture and vehicles 24 €54,635 €41,016 -€13,619 -24.9%
Other tangible fixed assets 26 €34,491 €31,468 -€3,023 -8.8%
Current assets 29/58 €1,070,646 €1,102,336 +€31,690 +3.0%
Stocks and contracts in progress 3 €172 - -€172
Stocks 30/36 €172 - -€172
Amounts receivable within one year 40/41 €153,876 €833,618 +€679,742 +441.7%
Trade receivables 40 €12,515 €56,231 +€43,717 +349.3%
Other amounts receivable 41 €141,361 €777,387 +€636,025 +449.9%
Current investments 50/53 €890,000 €250,000 -€640,000 -71.9%
Cash at bank and in hand 54/58 €18,266 €10,301 -€7,965 -43.6%
Deferred charges and accrued income 490/1 €8,332 €8,417 +€85 +1.0%
Total equity and liabilities 10/49 €1,160,601 €1,175,326 +€14,725 +1.3%
Equity 10/15 €947,029 €955,867 +€8,838 +0.9%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €885,029 €893,867 +€8,838 +1.0%
Non-distributable reserves 130/1 €18,617 €18,617 = 0.0%
Legal reserve 130 €18,617 €18,617 = 0.0%
Distributable reserves 133 €866,412 €875,250 +€8,838 +1.0%
Amounts payable 17/49 €213,572 €219,459 +€5,887 +2.8%
Amounts payable within one year 42/48 €200,252 €194,109 -€6,143 -3.1%
Trade debts 44 €27,630 €10,176 -€17,454 -63.2%
Suppliers 440/4 €27,630 €10,176 -€17,454 -63.2%
Taxes, remuneration and social security 45 €3,915 €12,827 +€8,912 +227.6%
Taxes 450/3 €3,915 €12,827 +€8,912 +227.6%
Other amounts payable 47/48 €168,706 €171,106 +€2,399 +1.4%
Accrued charges and deferred income 492/3 €13,321 €25,350 +€12,029 +90.3%
Remuneration, social security and pensions 62 -€8 - +€8
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €17,884 €18,286 +€402 +2.2%
Other operating charges 640/8 €2,472 €1,978 -€495 -20.0%
Gross operating margin 9900 -€22,552 €25,930 +€48,482
Operating profit (loss) 9901 -€42,901 €5,666 +€48,567
Financial income 75/76B €29,043 €17,182 -€11,861 -40.8%
Recurring financial income 75 €29,043 €17,182 -€11,861 -40.8%
Financial charges 65/66B €13,784 €12,899 -€885 -6.4%
Recurring financial charges 65 €13,784 €12,899 -€885 -6.4%
Profit (loss) for the period before taxes 9903 -€27,642 €9,948 +€37,590
Income taxes 67/77 €52 €1,110 +€1,058 +2044.7%
Profit (loss) for the period 9904 -€27,694 €8,838 +€36,532
Profit (loss) for the period to be appropriated 9905 -€27,694 €8,838 +€36,532

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.